Skip to main navigation

Who We Are
Our Portfolio
Pipeline
Media & Investors
- Media
- Investors
  - News Releases
  - Events
  - Financials
  - Governance
  - Stocks
  - Reports
  - Resources
Connect

We strive to put patients first and preserve their future possibilities

Investor Relations

Overview
News Releases
Events
Financials
Governance
Stock Info
Reports
Resources

Event Type Conference Presentation

Jun 13, 2024 11:00 AM EDT

UGN-102 12-Month Durability of Response Data Event

Listen to webcast

Upcoming events

There are no upcoming events available at this time.

Past events

Event Type Conference Presentation

Feb 8, 2024 11:00 AM EST

Guggenheim 6th Annual Biotechnology Conference

Listen to webcast

Event Type Conference Presentation

Jan 18, 2024 12:00 PM EST

2024 B Riley Healthcare Conference

Listen to webcast

Event Type Earnings Conference Call

Nov 14, 2023 10:00 AM EST

UroGen Pharma Q3 2023 Earnings Call

Listen to webcast

Event Type Conference Presentation

Sep 26, 2023 8:45 AM EDT

2023 Cantor Fitzgerald Global Healthcare Conference

Listen to webcast

Event Type Conference Presentation

Sep 12, 2023 10:00 AM EDT

H.C. Wainwright 25th Annual Global Investment Conference

Listen to webcast

Event Type Earnings Conference Call

Aug 10, 2023 10:00 AM EDT

UroGen Pharma Q2 2023 Earnings Call

Listen to webcast

Event Type Conference Presentation

Jul 27, 2023 10:00 AM EDT

UGN-102 Phase 3 ATLAS & ENVISION Topline Data Event

Webcast Replay

Event Type Conference Presentation

Jun 14, 2023 4:00 PM EDT

Goldman Sachs 44th Annual Global Healthcare Conference

Listen to webcast

Event Type Conference Presentation

Jun 9, 2023 12:45 PM EDT

Jefferies 2023 Healthcare Conference

Listen to webcast

Event Type Earnings Conference Call

May 11, 2023 10:00 AM EDT

UroGen Pharma Q1 2023 Earnings Call

Listen to webcast

First
Previous
Page 1
Current page 2
Page 3
Page 4
…
Next
Last

Presentations

Urogen Corporate Presentation – November 2024

New Horizons in Bladder Cancer: UGN-102 Duration of Response Results from the ENVISION Study

New Horizons in Bladder Cancer: Insights from Top-Line Data of ATLAS & ENVISION Studies

Who We Are
Our Portfolio
Pipeline
Media
Investors

Privacy Policy
Patent Notice
Terms of Use
Funding Requests

Follow Us: Linkedin opens in new window Twitter opens in new window

Connect

JELMYTO^®, UroGen^®, and RTGel^® are registered trademarks of UroGen Pharma, Ltd. All other trademarks are the property of their respective owners.

US-UGN-00269 05/24